Evaluation of soluble mesothelin-related peptides and MSLN genetic variability in asbestos-related diseases.

Radiol Oncol · 2020 · PMC7087423 · PMID 32187018

Europe PMC DOI

hedged sentence

0.0930

closest p · 1.9× alpha

0.0930

boldest claim

The sentences

did not reach statistical significancep = 0.093so close (0.05 < p ≤ 0.1)

For MSLN rs1057147 in the dominant model, the AUC was 0.621 (0.485–0.757) and did not reach statistical significance ( p = 0.093).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.